The sequence effect and gait festination in parkinson disease: contributors to freezing of gait?

Movement Disorders

Volumn 21, Issue 9, 2006, Pages 1419-1424

  Iansek, Robert ^a   Huxham, Frances ^a,b   McGinley, Jennifer ^a,c  

^a Kingston Centre   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Basal ganglia; Festination; Gait; Parkinson disease

Indexed keywords

AMANTADINE; BENSERAZIDE PLUS LEVODOPA; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; PERGOLIDE; SELEGILINE; SUMANIROLE; TOLCAPONE; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; ASSOCIATION; ATTENTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; GAIT DISORDER; HUMAN; HYPOKINESIA; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; ANTIPARKINSON AGENTS; ATTENTION; BASAL GANGLIA; CUES; DRUG THERAPY, COMBINATION; FEMALE; GAIT APRAXIA; HUMANS; HYPOKINESIA; LEVODOPA; MALE; MIDDLE AGED; MOBILITY LIMITATION; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; RISK FACTORS; SENSORY DEPRIVATION; VISUAL PERCEPTION; WALKING;

EID: 33750292573     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20998     Document Type: Article

References (26)

1. Gray P, Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nursing 2000;32:222-234.
2. Nieuwboer A, Dom R, De Weerdt W, Desloovere K, Fieuws S, Broens-Kaucsik E. Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease. Mov Disord 2001;16:1066-1075.
3. Lamberti P, Armenise S, Castaldo V, et al. Freezing gait in Parkinson's disease. Eur Neurol 1997;38:297-301.
4. Giladi N, McMahon D, Przedborski S, et al. Motor blocks in Parkinson's disease. Neurology 1992;42:333-339.
5. Giladi N, Treves TA, Simon ES, et al. Freezing of gait in patients with advanced Parkinson's disease. J Neural Transm 2001;108:53-61.
6. Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 2000;6:165-170.
7. Giladi N, McDermott M, Fahn S, et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 2001; 56:1712-1721.
8. Marsden CD, Parkes JD, Quinn N. Fluctuations of disability in Parkinson's disease: clinical aspects. In: Marsden CD, Fahn S, editors. Movement Disorders. London: Butterworth Scientific; 1981. p 96-122.
9. Cunnington R, Windischberger C, Deecke L, Moser E. The preparation and execution of self-initiated and externally-triggered. movement: a study of event-related fMRI. Neuroimage 2002;15: 373-385.
10. Georgiou N, Bradshaw JL, Iansek R, Phillips JG, Mattingley JB, Bradshaw JA. Reduction in external cues and movement sequencing in Parkinson's disease. J Neurol Neurosurg Psychiatry 1994; 57:368-370.
11. O'Shea S, Morris ME, Iansek R. Dual task interference during gait in people with Parkinson disease: effects of motor versus cognitive secondary tasks. Phys Ther 2002;82:888-897.
12. Bloem BR, Valkenburg VV, Slabbekoorn M, Willemsen MD. The multiple tasks test: development and normal strategies. Gait Posture 2001; 14:191-202.
13. Iansek R, Bradshaw J, Phillips J, Cunnington R, Morris M. Basal ganglia function and Parkinson's disease. In: Morris M, Iansek R, editors. Parkinson's disease: a team approach. Blackburn, Australia: Buscombe Vicprint; 1997. p 173-188.
14. Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson's disease. Brain 2001; 124(Pt. 11):2131-2146.
15. Morris M, Iansek R, McGinley J, Matyas T, Huxham F. 3-Dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder. Mov Disord 2005;20:40-50.
16. Fahn S, Elton RL, UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Falm S, editor. Recent developments in Parkinson's disease. New York: Macmillan; 1987. p153-163.
17. Lewis GN, Byblow WD, Walt SE. Stride length regulation in Parkinson's disease: the use of extrinsic, visual cues. Brain 2000; 123(Pt. 10):2077-2090.
18. Nieuwboer A, Dom R, De Weerdt W, Desloovere K, Janssens L, Stijn V. Electromyographic profiles of gait prior to onset of freezing episodes in patients with Parkinson's disease. Brain 2004;127: 1650-1660.
19. Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord 1998;13:428-437.
20. Hausdorff J, Schaafsma J, Balash Y, Bartels A, Gurevich T, Giladi N. Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait. Exp Brain Res 2003;149:187-194.
21. Plotnik M, Giladi N, Balash Y, Peretz C, Hausdorff JM. Is freezing of gait in Parkinson's disease related to asymmetric motor function? Ann Neurol 2005;57:656-663.
22. Abe K, Asai Y, Matsuo Y, et al. Classifying lower limb dynamics in Parkinson's disease. Brain Res Bull 2003;61:219-226.
23. Kompoliti K, Goetz CG, Leurgans S, Morrissey M, Siegel IM. "On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord 2000; 15:309-312.
24. Saint-Cyr JA, Taylor AE, Lang AE. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease. Neurology 1993;12(Suppl. 6):43.
25. Sweet RD, McDowell FH, Feigenson JS, Loranger AW, Goodell H. Mental symptoms in Parkinson's disease during chronic treatment with levodopa. Neurology 1976;26:305-310.
26. Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson's disease: normalization strategies and underlying mechanisms. Brain 1996; 119(Pt. 2):551-568.